Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.65M Sell
5,787
-1,117
-16% -$327K 0.05% 205
2023
Q4
$1.99M Sell
6,904
-1,677
-20% -$457K 0.04% 265
2023
Q3
$2.31M Buy
8,581
+1,042
+14% +$260K 0.05% 237
2023
Q2
$1.68M Sell
7,539
-66
-0.9% -$15.3K 0.04% 239
2023
Q1
$1.84M Buy
7,605
+1,382
+22% +$339K 0.05% 231
2022
Q4
$1.64M Sell
6,223
-376
-6% -$101K 0.04% 224
2022
Q3
$1.49M Buy
6,599
+211
+3% +$51.1K 0.03% 284
2022
Q2
$1.56M Buy
6,388
+1,395
+28% +$342K 0.04% 219
2022
Q1
$1.12M Sell
4,993
-12,410
-71% -$2.85M 0.04% 230
2021
Q4
$3.92M Buy
+17,403
New +$3.67M 0.15% 88

Other funds holding AMGN

Connectus Wealth's AMGN Position: Q1 2024 in Review

Connectus Wealth reduced its Amgen (AMGN) stake by 16% in Q1 2024, selling an estimated $327K and leaving 5,787 shares worth $1.65M. The position accounts for 0.05% of the portfolio, ranked #205.

Connectus Wealth first reported a position in AMGN in Q4 2021 and has held it in 10 quarters since. The position peaked at $3.92M in Q4 2021. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Connectus Wealth held 5,787 shares of Amgen worth $1.65M as of Q1 2024.
  • Connectus Wealth sold 1,117 Amgen shares in Q1 2024, an estimated $327K.
  • Amgen made up 0.05% of Connectus Wealth's portfolio in Q1 2024, its #205 holding.
  • Connectus Wealth first reported a position in Amgen in Q4 2021 and has held it in 10 quarters since.
  • Connectus Wealth's Amgen position peaked at $3.92M in Q4 2021.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.